Gene expressions of Th1 and Th2 cytokines in PBMC from patients with gastric carcinoma and their clinical significace

LIANG Jing,LI Yan,LIU Xiao-lin,XU Xiao-qun,ZHAO Yue-ran
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2009.02.021
2009-01-01
Abstract:Objective: To investigate the mRNA expressions of Th1 and Th2 cytokines in peripheral blood mononuclear cells(PB-MC) from patients with gastric carcinoma. Methods: The mRNA expressions of Th1/Th2 cytokines geng were detected by RT-PCR in 50 normal controls, 60 cases of gastric benign diseases and 102 patients with gastric carcinoma before and after chemotherapy. Results: The mRNA expressions of Th1 and Th2 cytokines had no significant difference in PBMCs from those between benign diseases and the normal controls, P>0.05. The mRNA expressions of IL-4, IL-6 and IL-10 in PBMCs from patients with gastric carcinoma were significantly higher than those from benign diseases and the normal controls(P<0.05), and correlated with the patients' clinical stages and differential degrees, P<0.05. There were only 3 patients with a positive expression of IFN-γ(3/102) and 7 patients with a positive IL-2 mRNA expression in all the patients with gastric carcinoma, which were lower than those of benign diseases and the normal controls. The expression of Th1 was increased significantly, while that of Th2 was decreased in the group sentitive to chemotherapy of gastric carcinoma patients, P < 0.05. There was no difference in the mRNA expressions of Th1 and Th2 in the group non-sensitive to chemotherapy, P > 0.05. Conclusion: The detection of the gene expressions of Th1 and Th2 cytokines in PBMC from patients with gastric carcinoma is a sentitive and accurate means of evaluating the function of patient's conditions and guiding the therapy.
What problem does this paper attempt to address?